Key facts
- Beijing Baishihekang Pharmaceutical Technology’s last known valuation is $138.0M (Apr 2025).
- It has raised $6.8M; the latest was Early Stage VC ($6.8M) in Apr 2025.
- Notable investors include Beijing Zhongguancun Venture Capital Development, Beijing Bewinner Communications Company.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Beijing Baishihekang Pharmaceutical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Beijing Baishihekang Pharmaceutical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beijing Baishihekang Pharmaceutical Technology
Developer of a pharmaceutical technology designed to advance medical research and development. The company offers innovative biobased materials and comprehensive technical services, enabling healthcare professionals to enhance patient care and treatment outcomes.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Beijing Baishihekang Pharmaceutical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beijing Baishihekang Pharmaceutical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beijing Baishihekang Pharmaceutical Technology in its N-PORT filings yet. We sweep new filings monthly.